Exosome Research Products Market Worth $264 Million by 2024 - Exclusive Report by MarketsandMarkets™

Exosome Research Products Market Worth $264 Million by 2024 - Exclusive Report by MarketsandMarkets™

PR Newswire

CHICAGO, Feb. 27, 2019

CHICAGO, Feb. 27, 2019 /PRNewswire/ -- According to the new market research report "Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024", published by MarketsandMarkets™, the global Exosome Research Products Market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period.

MarketsandMarkets_Logo

Don't miss out on business opportunities in Exosome Research Products Market.

The factors supporting market growth include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.

Non-cancer applications segment is expected to grow at the highest CAGR during the forecast period

Based on applications, the Exosome Research Products Market is segmented into cancer and non-cancer applications. The non-cancer applications segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing research on exosomes for non-cancerous applications, which includes prenatal health, neurodegenerative diseases, CNS disorders, infectious diseases, organ transplant diagnostics, and others.

Browse in-depth TOC on "Exosome Research Products Market"

74 – Tables

34 – Figures  

127 – Pages  

Get 10% Free Customization on this Report: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=224782498

Academic & research institutes use exosome research products for various cancer and stem cell research studies

Based on end user, the Exosome Research Products Market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. In 2018, the academic & research institutes segment accounted for the largest share of the Exosome Research Products Market. The large share of this segment can be attributed to the growing use of exosomes in cancer and stem cell research, increasing number of cancer and stem cell research projects across the globe, and rising public-private funding for exosome-based research.

North America was the largest regional market for exosome research products in 2018

The global Exosome Research Products Market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World. In 2018, North America accounted for the largest share of the market. The large share of the North American market can be attributed to factors such as the availability of government funding for life science research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research. In 2018, Europe was the second-largest regional market for exosome research products owing to a large number of ongoing research studies and increasing government funding for life science research activities in European countries.

Inquiry Before Buying: 

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=224782498

The global Exosome Research Products Market is highly competitive owing to the presence of several large and small players. Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX Pharmagen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global Exosome Research Products Market.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/exosome-research-product-market.asp 
Visit Our Website: https://www.marketsandmarkets.com           

Voltar noticias em Inglês